Literature DB >> 20973832

History of leukemia-lymphoma cell lines.

Hans G Drexler1, Roderick A F Macleod.   

Abstract

We outline the near 50-year history of leukemia-lymphoma (LL) cell lines - a key model system in biomedicine. Due to the detailed documentation of their oncogenomic and transcriptional alterations via recent advances in molecular medicine, LL cell lines may be fitted to parent tumors with a degree of precision unattainable in other cancers. We have surveyed the corpus of published LL cell lines and found 637 examples that meet minimum standards of authentication and characterization. Alarmingly, the rate of establishment of new LL cell lines has plummeted over the last decade. Although the main hematopoietic developmental cell types are represented by cell lines, some LL categories stubbornly resist establishment in vitro. The advent of engineering techniques for immortalizing primary human cells that maintain differentiation means the time is ripe for renewed search for in vitro models from un(der)represented hematologic entities. Given their manifold applications in biomedicine, there is little doubt that LL-derived cell lines will continue to play a vital part well into the next half-century as well.
© 2010 The Authors. Human Cell © 2010 Japan Human Cell Society.

Entities:  

Mesh:

Year:  2010        PMID: 20973832     DOI: 10.1111/j.1749-0774.2010.00087.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  19 in total

1.  Guidelines for the characterization and publication of human malignant hematopoietic cell lines.

Authors:  H G Drexler; Y Matsuo
Journal:  Leukemia       Date:  1999-06       Impact factor: 11.528

2.  Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations.

Authors:  F G Rücker; S Sander; K Döhner; H Döhner; J R Pollack; L Bullinger
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

3.  Public repositories: users reluctant to give materials.

Authors:  Roderick A F MacLeod; Hans G Drexler
Journal:  Nature       Date:  2006-02-23       Impact factor: 49.962

4.  The growth in vitro of single isolated tissue cells.

Authors:  K K SANFORD; W R EARLE; G D LIKELY
Journal:  J Natl Cancer Inst       Date:  1948-12       Impact factor: 13.506

5.  Leukaemia cell lines are robust in vitro models.

Authors:  Roderick A F MacLeod; Hans G Drexler
Journal:  Br J Haematol       Date:  2008-04-28       Impact factor: 6.998

6.  Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.

Authors:  A Andersson; P Edén; D Lindgren; J Nilsson; C Lassen; J Heldrup; M Fontes; A Borg; F Mitelman; B Johansson; M Höglund; T Fioretos
Journal:  Leukemia       Date:  2005-06       Impact factor: 11.528

7.  Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI).

Authors:  Rickard Sandberg; Ingemar Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

8.  Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Authors:  Martin L Sos; Kathrin Michel; Thomas Zander; Jonathan Weiss; Peter Frommolt; Martin Peifer; Danan Li; Roland Ullrich; Mirjam Koker; Florian Fischer; Takeshi Shimamura; Daniel Rauh; Craig Mermel; Stefanie Fischer; Isabel Stückrath; Stefanie Heynck; Rameen Beroukhim; William Lin; Wendy Winckler; Kinjal Shah; Thomas LaFramboise; Whei F Moriarty; Megan Hanna; Laura Tolosi; Jörg Rahnenführer; Roel Verhaak; Derek Chiang; Gad Getz; Martin Hellmich; Jürgen Wolf; Luc Girard; Michael Peyton; Barbara A Weir; Tzu-Hsiu Chen; Heidi Greulich; Jordi Barretina; Geoffrey I Shapiro; Levi A Garraway; Adi F Gazdar; John D Minna; Matthew Meyerson; Kwok-Kin Wong; Roman K Thomas
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

9.  Human leukemia cell lines--clinical and theoretical significances.

Authors:  Y Matsuo; J Minowada
Journal:  Hum Cell       Date:  1988-09       Impact factor: 4.174

Review 10.  Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.

Authors:  H G Drexler
Journal:  Leukemia       Date:  1998-06       Impact factor: 11.528

View more
  10 in total

1.  Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1.

Authors:  Kasyapa S Chitta; Aneel Paulus; Sikander Ailawadhi; Barbara A Foster; Michael T Moser; Petr Starostik; Aisha Masood; Taimur Sher; Kena C Miller; Dan M Iancu; Jeffrey Conroy; Norma J Nowak; Sheila N Sait; David A Personett; Morton Coleman; Richard R Furman; Peter Martin; Stephen M Ansell; Kelvin Lee; Asher A Chanan-Khan
Journal:  Leuk Lymphoma       Date:  2012-08-27

2.  Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736.

Authors:  Andrew S Moore; Amir Faisal; Grace W Y Mak; Farideh Miraki-Moud; Vassilios Bavetsias; Melanie Valenti; Gary Box; Albert Hallsworth; Alexis de Haven Brandon; Cristina P R Xavier; Randal Stronge; Andrew D J Pearson; Julian Blagg; Florence I Raynaud; Rajesh Chopra; Suzanne A Eccles; David C Taussig; Spiros Linardopoulos
Journal:  Blood Adv       Date:  2020-04-14

3.  A reliable Raman-spectroscopy-based approach for diagnosis, classification and follow-up of B-cell acute lymphoblastic leukemia.

Authors:  Stefano Managò; Carmen Valente; Peppino Mirabelli; Diego Circolo; Filomena Basile; Daniela Corda; Anna Chiara De Luca
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

4.  Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions.

Authors:  Yiping Zhu; Rong Yang; Ju Gao; Yanle Zhang; Ge Zhang; Ling Gu
Journal:  Cancer Cell Int       Date:  2019-04-29       Impact factor: 5.722

5.  CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia.

Authors:  Franz Ketzer; Hend Abdelrasoul; Mona Vogel; Ralf Marienfeld; Markus Müschen; Hassan Jumaa; Thomas Wirth; Alexey Ushmorov
Journal:  Oncogenesis       Date:  2022-01-10       Impact factor: 6.524

6.  Misidentified biomedical resources: Journal guidelines are not a quick fix.

Authors:  Wytske M Hepkema; Serge P J M Horbach; Joyce M Hoek; Willem Halffman
Journal:  Int J Cancer       Date:  2021-12-07       Impact factor: 7.316

7.  Massive transcriptional perturbation in subgroups of diffuse large B-cell lymphomas.

Authors:  Maciej Rosolowski; Jürgen Läuter; Dmitriy Abramov; Hans G Drexler; Michael Hummel; Wolfram Klapper; Roderick A F Macleod; Shoji Pellissery; Friedemann Horn; Reiner Siebert; Markus Loeffler
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

8.  Differential Activity of Voltage- and Ca2+-Dependent Potassium Channels in Leukemic T Cell Lines: Jurkat Cells Represent an Exceptional Case.

Authors:  Salvador Valle-Reyes; Georgina Valencia-Cruz; Liliana Liñan-Rico; Igor Pottosin; Oxana Dobrovinskaya
Journal:  Front Physiol       Date:  2018-05-09       Impact factor: 4.566

9.  Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis.

Authors:  Kari Högstrand; Stephanie Darmanin; TachaZi Plym Forshell; Alf Grandien
Journal:  Oncotarget       Date:  2018-04-20

10.  Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations.

Authors:  Fumio Kasai; Hiroya Asou; Midori Ozawa; Kazuhiko Kobayashi; Hiroyuki Kuramitsu; Motonobu Satoh; Arihiro Kohara; Yasuhiko Kaneko; Machiko Kawamura
Journal:  Hum Cell       Date:  2020-03-16       Impact factor: 4.174

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.